Jacob P. Lalezari, M.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when CytoDyn Inc. publishes a filing, an earnings call transcript or a press release.
Get CYDY alertsAbout Jacob P. Lalezari, M.D.
Jacob P. Lalezari, M.D. is recorded as CEO at CytoDyn Inc. (CYDY) since November 17, 2023. CytoDyn Inc. reported in an 8-K filed January 29, 2024 that Jacob P. Lalezari, M.D. was appointed Chief Executive Officer, effective January 26, 2024. CytoDyn Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytoDyn Inc. includes Dr. Jacob P. Lalezari (CEO), Jacob P. Lalezari (CEO), Robert E. Hoffman (CEO and CFO) and 7 others.
“On January 26, 2024, CytoDyn Inc., a Delaware corporation (the "Company"), entered into an employment agreement with Jacob P. Lalezari, M.D. (the "Employment Agreement"), under which he will be employed as the Company's Chief Executive Officer and will serve as its principal executive officer, effective as of January 26, 2024.”
Affiliation history
-
Current
2023-11-17–present
Company network
Leadership on record at CytoDyn Inc.
- Dr. Jacob P. Lalezari CEO
- Jacob P. Lalezari CEO
- Robert E. Hoffman CEO, CFO
- Tanya Durkee Urbach Chairman
- Mitchell Cohen CFO, Chief Accounting Officer
- Dr. Christopher P. Recknor, M.D. COO
- Arian Colachis General Counsel
- Alan P. Timmins Board Member
- Gordon A. Gardiner Board Member
- Jordon G. Naydenov Board Member